Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Booth

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.
The New England Journal of Medicine|May 11, 2021
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase DeficiencyDonald B Kohn, Claire Booth, Kit L Shaw, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2019
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC studyFrancesca Ferrua, Stefania Galimberti, Virginie Courteille, et al.
The Journal of Clinical Investigation|July 4, 2018
Inherited p40phox deficiency differs from classic chronic granulomatous diseaseAnnemarie van de Geer, Alejandro Nieto-Patlán, Douglas B Kuhns, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2019
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG DeficiencyJocelyn R Farmer, Zsofia Foldvari, Boglarka Ujhazi, et al.
Science Immunology|January 10, 2025
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signatureMarita Bosticardo, Kerry Dobbs, Ottavia M Delmonte, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.
The New England Journal of Medicine|May 11, 2021
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase DeficiencyDonald B Kohn, Claire Booth, Kit L Shaw, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2019
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC studyFrancesca Ferrua, Stefania Galimberti, Virginie Courteille, et al.
The Journal of Clinical Investigation|July 4, 2018
Inherited p40phox deficiency differs from classic chronic granulomatous diseaseAnnemarie van de Geer, Alejandro Nieto-Patlán, Douglas B Kuhns, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2019
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG DeficiencyJocelyn R Farmer, Zsofia Foldvari, Boglarka Ujhazi, et al.
Science Immunology|January 10, 2025
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signatureMarita Bosticardo, Kerry Dobbs, Ottavia M Delmonte, et al.
Pageof 9